These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27792216)

  • 1. Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.
    Polyzos SA
    Minerva Endocrinol; 2017 Jun; 42(2):89-91. PubMed ID: 27792216
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of metabolic and endocrine causes of mental retardation.
    French JH; Graziani LJ; Scheinberg LC
    Mod Treat; 1967 Sep; 4(5):987-1052. PubMed ID: 4863339
    [No Abstract]   [Full Text] [Related]  

  • 3. Status of endocrine disease with HIV infection.
    Donovan DS; Dluhy RG
    Curr Ther Endocrinol Metab; 1994; 5():190-4. PubMed ID: 7704711
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial overview: Endocrine and metabolic diseases: Waistline weapons: new therapeutic avenues for the treatment of obesity and metabolic disease.
    Murphy KG
    Curr Opin Pharmacol; 2015 Dec; 25():iv-vi. PubMed ID: 26559147
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management.
    Polyzos SA; Mantzoros CS
    Metabolism; 2024 Aug; 157():155936. PubMed ID: 38763229
    [No Abstract]   [Full Text] [Related]  

  • 6. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.
    Eslam M; Ahmed A; Després JP; Jha V; Halford JCG; Wei Chieh JT; Harris DCH; Nangaku M; Colagiuri S; Targher G; Joshi S; Byrne CD; Khunti K; Nguyen MH; Gish RG; George J
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):743-753. PubMed ID: 34265276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Rauh C; Dufour JF
    Ther Umsch; 2017 Jul; 74(3):87-92. PubMed ID: 28777051
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary Manifestations of Endocrine and Metabolic Diseases in Children.
    Broomfield AA; Padidela R; Wilkinson S
    Pediatr Clin North Am; 2021 Feb; 68(1):81-102. PubMed ID: 33228944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.
    Ji D; Zhang M; Qin E; Zhang L; Xu J; Wang Y; Cheng G; Wang F; Lau G
    Metabolism; 2021 Feb; 115():154437. PubMed ID: 33220249
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing endocrine and metabolic problems in the patient with advanced cancer.
    Segaloff A
    JAMA; 1981 Jan; 245(2):177-9. PubMed ID: 7452837
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endocrine disorders and metabolic disorders].
    Matsunaga T; Tomita M; Uchimura N
    Nihon Rinsho; 2012 Jan; 70(1):67-72. PubMed ID: 22413495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic, endocrine, and cystic disorders of the salivary glands.
    McCabe BF
    Trans Am Acad Ophthalmol Otolaryngol; 1965; 69(6):1122-5. PubMed ID: 5861650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Local and general endocrine and metabolic disorders in predisposition to respiratory diseases].
    Bisetti A
    Arch Monaldi Mal Torace; 1989; 44(1-3):301-4. PubMed ID: 2520579
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine and metabolic disturbances associated with leukemia.
    Tashima CK
    Chic Med Sch Q; 1967; 27(1):17-21. PubMed ID: 4867457
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes.
    Krishan S
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S77-81. PubMed ID: 26810159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Muscular dystrophies of metabolic and endocrine origin].
    Pages A; Marty-Double C; Baldet P
    Ann Anat Pathol (Paris); 1973; 18(2):141-68. PubMed ID: 4577567
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly.
    Schneider JB; Norman RA
    Dermatol Clin; 2004 Jan; 22(1):23-31, vi. PubMed ID: 15018007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Fatty Liver Disease: Does This Metabolic Condition Have Brain Function Sequelae?
    Beydoun MA; Canas JA
    Neurology; 2022 Aug; 99(6):225-226. PubMed ID: 35940894
    [No Abstract]   [Full Text] [Related]  

  • 19. Skeletal disease resulting from disturbed endocrine function or from errors in metabolism.
    FREEMAN S
    Instr Course Lect; 1957; 14():286-91. PubMed ID: 13524961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):418-434. PubMed ID: 38858192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.